ZBNA
TARS icon

Zions Bancorporation, National Association’s Tarsus Pharmaceuticals TARS Stock Holding History

Zions Bancorporation, National Association’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.65K Buy
58
+44
+314% +$2.81K ﹤0.01% 1159
2026
Q1 		$982 Buy
+14
New +$978 ﹤0.01% 1353

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Zions Bancorporation, National Association's TARS Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Tarsus Pharmaceuticals (TARS) stake by 314% in Q2 2026, buying an estimated $2.81K and bringing the position to 58 shares worth $3.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

Zions Bancorporation, National Association first reported a position in TARS in Q1 2026 and has held it in 2 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Zions Bancorporation, National Association held 58 shares of Tarsus Pharmaceuticals worth $3.65K as of Q2 2026.
  • Zions Bancorporation, National Association bought 44 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $2.81K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1159 holding.
  • Zions Bancorporation, National Association first reported a position in Tarsus Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.